BCL6 and diffuse large B-cell lymphoma: Although no cogent evidence supports the specialty of ubiquitin–proteasome regulator in this subtype, inhibitors regulating the NF-κB pathway exhibited cytotoxicity selectively towards ABC-DLBCL [327], which is more prominent in the DHL-BCL6.